ALB and small cell lung carcinoma: Although our study was limited to the data from a single center and with missing values and variables that are critical for a more complete assessment, our findings highlight the importance of baseline serum albumin level and dNLR in predicting the overall survival of SCLC patients undergoing ICI-involved immunochemotherapy.